Back to Search
Start Over
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
- Source :
- Blood Cancer Journal, BLOOD CANCER JOURNAL, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname, Blood Cancer Journal, Vol 11, Iss 10, Pp 1-5 (2021)
- Publication Year :
- 2021
- Publisher :
- Nature Publishing Group UK, 2021.
- Subjects :
- Oncology
medicine.medical_specialty
Mitoxantrone
business.industry
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Myeloid leukemia
Drug development
Hematology
Alvocidib
Phase II trials
Acute myeloid leukaemia
chemistry.chemical_compound
FLAVOPIRIDOL
chemistry
Internal medicine
Relapsed refractory
Correspondence
medicine
Cytarabine
Biomarker Analysis
MCL-1
business
RC254-282
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 20445385
- Volume :
- 11
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Blood Cancer Journal
- Accession number :
- edsair.doi.dedup.....3942dd1e54bd08a10bcfddea324cde57